-
1 Comment
Immuno-Biological Laboratories Co., Ltd is currently in a long term downtrend where the price is trading 5.7% below its 200 day moving average.
From a valuation standpoint, the stock is 88.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
Immuno-Biological Laboratories Co., Ltd's total revenue rose by 4.8% to $167M since the same quarter in the previous year.
Its net income has increased by 11.6% to $-73M since the same quarter in the previous year.
Based on the above factors, Immuno-Biological Laboratories Co., Ltd gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Biotechnology |
Exchange | TSE |
CurrencyCode | JPY |
ISIN | JP3921300004 |
Beta | 0.05 |
---|---|
Market Cap | 4B |
PE Ratio | 18.46 |
Target Price | None |
Dividend Yield | None |
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4570.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025